Yoshiki Eto

Publicacions destacades

• MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice

  Autors:

  Broset E; Saubi N; Guitart N; Aguilo N; Uranga S;

  (...)

  Eto Y; Hanke T; Gonzalo-Asensio J; Martín C; Joseph-Munné J.

  Veure llistat complet d'autors

  Referència: MOL THER METHODS CLIN DEV.

• Construction and Characterization of Recombinant MTBVAC. HIV, a New Live Attenuated Vaccine Against HIV and Tuberculosis

  Autors:

  Saubi, Narcis; Broset, Esther; Guitart, Nuria; Aguilo, Nacho; Uranga, Santiago;

  (...)

  Eto, Yoshiki; Hanke, Tomas; Gonzalo-Asensio, Jesus; Martin, Carlos; Joseph, Joan;.

  Veure llistat complet d'autors

  Referència: AIDS RESEARCH AND HUMAN RETROVIRUSES.

• Preclinical development of BCG.HIVA^2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity

  Autors:

  Mahant A.; Saubi N.; Eto Y.; Guitart N.; Gatell J.;

  Hanke T.; Joseph J..

  Referència: HUMAN VACCINES & IMMUNOTHERAPEUTICS.

• Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG

  Autors:

  Saubí N; Gea-Mallorquí E; Ferrer P; Hurtado C; Sánchez-Úbeda S;

  Eto Y; Gatell J; Hanke T; Joseph J.

  Referència: MOL THER METHODS CLIN DEV.

• Full blood count values as a predictor of poor outcome of pneumonia among HIV-infected patients

  Autors:

  Camon, S.; Quiros, C.; Saubi, N.; Moreno, A.; Marcos, M. A.;

  (...)

  Monclus, E.; Brown, J.; McHugh, T. D.; Mallolas, J.; Perello, R.;.

  Veure llistat complet d'autors

  Referència: BMC INFECTIOUS DISEASES 2018.

• Acute respiratory infection: first clinical manifestation of active infection with cytomegalovirus in HIV patients presenting to the emergency department

  Autors:

  Perello, R.; Vergara, A.; Camon, S.; Saubi, N.; Eto, Y.;

  Quiros, C.; Priu, I; Moreno, A.; Martinez, E.; Marcos, M. A.;.

  Referència: SIGNA VITAE 2016.